- Report
- April 2025
- 94 Pages
Global
From €5308EUR$5,600USD£4,434GBP
- Report
- February 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Drug Pipelines
- July 2024
- 60 Pages
Global
From €1185EUR$1,250USD£990GBP
- Report
- March 2024
- 159 Pages
Global
From €7535EUR$7,950USD£6,295GBP
- Report
- April 2025
- 50 Pages
Global
From €2512EUR$2,650USD£2,098GBP
- Report
- April 2025
- 50 Pages
Global
From €2512EUR$2,650USD£2,098GBP
- Report
- April 2025
- 50 Pages
Global
From €2512EUR$2,650USD£2,098GBP
Propranolol is a beta-blocker drug used to treat cardiovascular diseases such as hypertension, angina, and arrhythmias. It works by blocking the action of certain natural chemicals in the body, such as epinephrine, that affect the heart and blood vessels. Propranolol is also used to treat certain types of tremors, and to prevent migraine headaches. It is available in both oral and intravenous forms.
Propranolol is one of the most commonly prescribed cardiovascular drugs, and is widely used in the treatment of hypertension, angina, and arrhythmias. It is also used to treat certain types of tremors, and to prevent migraine headaches. It is generally well tolerated, with few side effects.
The propranolol market is highly competitive, with many companies offering generic and branded versions of the drug. Some of the major players in the market include Pfizer, Novartis, Merck, Sanofi, and GlaxoSmithKline. Show Less Read more